Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish Recommendations 2007

References

• UNAIDS, WHO. AIDS Epidemic Update. http://www.unaids.org/en/KnowledgeCentre/HIVData/EpiUpdate/EpiUpdArchive/2007default.asp.
   Google Scholar
• Coovadia HM, Rollins NC, Bland RM, Little K, Coutsoudis A, Bennish ML, et al. Mother-to-child transmission of HIV-1 infection during exclusive breast-feeding in the first 6 months of life: an intervention cohort study. Lancet 2007; 369: 1107–16
   PubMed Web of Science ®Google Scholar
• Mofenson LM, Lambert JS, Stiehm ER, Bethel J, Meyer WA III, Whitehouse J, et al. Risk factors for perinatal transmission of human immunodeficiency virus type-1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team. N Engl J Med 1999; 341: 385–93
   PubMed Web of Science ®Google Scholar
• Mandelbrot L, Mayaux MJ, Bongain A, Berrebi A, Moudoub-Jeanpetit Y, Benifla JL, et al. Obstetric factors and mother-to-child transmission of human immunodeficiency virus type-1: the French perinatal cohorts. SEROGEST French Pediatric HIV Infection Study Group. Am J Obstet Gynecol 1996; 175: 661–7
   PubMed Web of Science ®Google Scholar
• O'Donovan D, Ariyoshi K, Milligan P, Ota M, Yamuah L, Sarge-Njie R, et al. Maternal plasma viral RNA levels determine marked differences in mother-to-child transmission rates of HIV-1 and HIV-2 in The Gambia. MRC/Gambia Government/University College London Medical School working group on mother-child transmission of HIV. AIDS 2000; 14: 441–8
   PubMed Web of Science ®Google Scholar
• The International Perinatal HIV Group. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type-1: a meta-analysis of 15 prospective cohort studies. N Engl J Med 1999; 340: 977–87
   PubMed Web of Science ®Google Scholar
• European Collaborative Study. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. CID 2005; 40: 458–65
   PubMed Web of Science ®Google Scholar
• Ioannidis JP, Tatsioni A, Abrams EJ, Bulterys M, Coombs RW, Goedert JJ, et al. Maternal viral load and rate of disease progression among vertically HIV-1-infected children: an international meta-analysis. AIDS 2004; 18: 99–108
   PubMed Web of Science ®Google Scholar
• Navér L, Lindgren S, Belfrage E, Gyllensten K, Lidman K, Gisslen M, et al. Children born to HIV-1-infected women in Sweden in 1982–2003: trends in epidemiology and vertical transmission. J Acquir Immune Defic Syndr 2006; 42: 484–9
   PubMed Web of Science ®Google Scholar
• Kourtis AP, Schmid CH, Jamieson DJ, Lau J. Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis. AIDS 2007; 21: 607–15
   PubMed Web of Science ®Google Scholar
• Josephson F, Albert J, Flamholc L, Gisslen M, Karlstrom O, Lindgren SR, et al. Antiretroviral treatment of HIV infection: Swedish recommendations 2007. Scand J Infect Dis 2007; 39: 486–507
   PubMed Web of Science ®Google Scholar
• Jourdain G, Ngo-Giang-Huong N, Le Coeur S, Bowonwatanuwong C, Kantipong P, Leechanachai P, et al. Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy. N Engl J Med 2004; 351: 229–40
   PubMed Web of Science ®Google Scholar
• Mirochnick M, Stek A, Acevedo M, Keller M, Holland D, Capparelli E, et al. Safety and pharmacokinetics of nelfinavir coadministered with zidovudine and lamivudine in infants during the first 6 weeks of life. J Acquir Immune Defic Syndr 2005; 39: 189–94
   PubMed Web of Science ®Google Scholar
• Ripamonti D, Cattaneo D, Maggiolo F, Airoldi M, Frigerio L, Bertuletti P, et al. Atazanavir plus low-dose ritonavir in pregnancy: pharmacokinetics and placental transfer. AIDS 2007; 21: 2409–15
   PubMed Web of Science ®Google Scholar
• Stek AM, Mirochnick M, Capparelli E, Best BM, Hu C, Burchett SK, et al. Reduced lopinavir exposure during pregnancy. AIDS 2006; 20: 1931–9
   PubMed Web of Science ®Google Scholar
• Boffito M, Arnaudo I, Raiteri R, Bonora S, Sinicco A, Di Garbo A, et al. Clinical use of lopinavir/ritonavir in a salvage therapy setting: pharmacokinetics and pharmacodynamics. AIDS 2002; 16: 2081–3
   PubMed Web of Science ®Google Scholar
• Gonzalez de Requena D, Gallego O, Corral A, Jimenez-Nacher I, Soriano V. Higher efavirenz concentrations determine the response to viruses carrying non-nucleoside reverse transcriptase resistance mutations. AIDS 2004; 18: 2091–4
   PubMed Web of Science ®Google Scholar
• The Antiretroviral Pregnancy Registry. Interim Report 1 January 1989 through 31 January 2007. www.apregistry.com 2007.
   Google Scholar
• Watts DH, Li D, Handelsman E, Tilson H, Paul M, Foca M, et al. Assessment of birth defects according to maternal therapy among infants in the Women and Infants Transmission Study. J Acquir Immune Defic Syndr 2007; 44: 299–305
   PubMed Web of Science ®Google Scholar
• Barret B, Tardieu M, Rustin P, Lacroix C, Chabrol B, Desguerre I, et al. Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: clinical screening in a large prospective cohort. AIDS 2003; 17: 1769–85
   PubMed Web of Science ®Google Scholar
• European Collaborative Study. Exposure to antiretroviral therapy in utero or early life: the health of uninfected children born to HIV-infected women. J Acquir Immune Defic Syndr 2003; 32: 380–7
   PubMed Web of Science ®Google Scholar
• The Perinatal Safety Review Working Group. Nucleoside exposure in the children of HIV-infected women receiving antiretroviral drugs: absence of clear evidence for mitochondrial disease in children who died before 5 y of age in 5 United States cohorts. J Acquir Immune Defic Syndr 2000; 25: 261–8
   PubMed Web of Science ®Google Scholar
• Socialstyrelsens föreskrifter om infektionsscreening av gravida. SOSFS 2004;13.
   Google Scholar
• Somigliana E, Bucceri AM, Tibaldi C, Alberico S, Ravizza M, Savasi V, et al. Early invasive diagnostic techniques in pregnant women who are infected with the HIV: a multicentre case series. Am J Obstet Gynecol 2005; 193: 437–42
   PubMed Web of Science ®Google Scholar
• Coll O, Suy A, Hernandez S, Pisa S, Lonca M, Thorne C, et al. Prenatal diagnosis in human immunodeficiency virus-infected women: a new screening programme for chromosomal anomalies. Am J Obstet Gynecol 2006; 194: 192–8
   PubMed Web of Science ®Google Scholar
• Public Health Service Task Force. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. http://AIDSinfo.nih.gov/ 2006.
   Google Scholar
• Lallemant M, Jourdain G, Le Coeur S, Mary JY, Ngo-Giang-Huong N, Koetsawang S, et al. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. N Engl J Med 2004; 351: 217–28
   PubMed Web of Science ®Google Scholar
• Hitti J, Frenkel LM, Stek AM, Nachman SA, Baker D, Gonzalez-Garcia A, et al. Maternal toxicity with continuous nevirapine in pregnancy: results from PACTG 1022. J Acquir Immune Defic Syndr 2004; 36: 772–6
   PubMed Web of Science ®Google Scholar